Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment guidelines news

Show

From To
HIV/AIDS Update - Tentative approval for Lamivudine and Tenofovir DF Fixed Dose Combination Tablets, 300 mg/300 mg

the Food and Drug Administration (FDA) granted tentative approval for lamivudine and tenofovir DF Fixed Dose Combination Tablets, 300 mg/300 mg indicated in combination with other antiretrovirals for the treatment of HIV-1 infection in adults and

Published
10 March 2011
From
PharmaLive
Malawi: Challenges Ahead in HIV Treatment - Doctors Without Borders

New directives from the World Health Organization (WHO) have created both opportunities and challenges, particularly financial ones.

Published
15 February 2011
From
Doctors without Borders
India: ART for HIV will begin at higher CD4 count soon

he cut-off level to begin anti-retroviral treatment (ART) for people living with HIV (PLHIV) is set to be raised to 350 CD4 count from the existing 250.

Published
28 January 2011
From
Times of India
Uganda: Government Rejects Experts Call for Early HIV Treatment

Infectious disease specialists' want therapy for patients diagnosed with HIV/Aids to be administered as soon as they have been tested positive to protect them against opportunistic diseases like tuberculosis. However, the government will not heed the call on the grounds that it is not financially sustainable.

Published
28 January 2011
From
All Africa
Thailand updates treatment guidelines

The Thai Network for People Living with HIV/AIDS support the Public Health Ministry’s policy to prescribe anti-AIDS drugs to patients with the CD4 count of less than 350, a change from the current level of less than 200.

Published
19 January 2011
From
National News Bureau of Thailand
Updates to US HIV treatment guidelines

The United States Department of Health and Human Services released a number of updates to its HIV treatment guidelines for adults on January 10th. These include: A refinement

Published
11 January 2011
By
Keith Alcorn
Why start antiretroviral therapy for people living with HIV so late? - Modern Ghana

Studies indicate that there are enormous public health benefits of starting antiretroviral therapy (ART) earlier for people living with HIV (PLHIV) then why is ART started so late?

Published
11 January 2011
From
Ghana Web
Most used ARV regimen in South Africa may yield poorest survival

Of five first-line antiretroviral (ARV) regimens considered in a South African modeling study, the one used most today—stavudine, lamivudine, and nevirapine—yielded the poorest quality-adjusted survival and cost more (in a cost-effectiveness analysis) than combined zidovudine, lamivudine, and nevirapine.

Published
07 January 2011
From
International AIDS Society
Italy tells its regions: “supply these innovative drugs”

Italy’s medicines agency, AIFA, has published the list of innovative medicines which the country’s regions and provinces are now required to make available to patients. Included are raltegravir and maraviroc.

Published
05 January 2011
From
Pharma Times
Earlier Initiation Of Antiretroviral Therapy Should Be The Highest Priority For Global Expansion Of HIV Patient Care

Earlier initiation of antiretroviral therapy should be the highest priority for global expansion of HIV patient care. This finding, from a paper published in this week's PLoS Medicine, should help resource-limited nations to phase in the implementation of the new 2010 WHO recommendations for HIV treatment...

Published
22 December 2010
From
HIV / AIDS News From Medical News Today

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.